General
laparoscopic robotic-assisted prostatectomy
incontinence
IMRT
benign prostatic hyperplasia
prostate cancer
prostate guidelines
four-topic ethical approach
radiation therapy
health disparities
rising PSA castrate resistant prostate cancer
puerto ricans
male infertility
recruitment
sleep disturbance
penile cancer
radiotherapy
plant-based foods
historical perspectives
hormonal therapy
urinary obstruction
shared decision-making
health literacy
diagnostics
frailty
african-american men
kidney stones
african american
kidney cancer
erectile dysfunction
GU Infections
stricture
ethics
hormone replacement therapy
communication
painful bladder syndromeinterstitial cystitis
genetics
male hypogonadism
PET imaging
ethical decision-making
CRPC
depression
abscess
prostate lung colorectal and ovarian plco cancer screening trial
penile neoplasm
partners
screening for prostate cancer
genetic testing for prostate cancer
inequality
public health
renal cell carcinoma
UTI
new treatments
urinary incontinence treatment
androgen deprivation therapy
sexual dysfunction
fatigue
prostate-specific antigen
digital rectal examination
gleason score
metastatic castrate resistant prostate cnacer
androgen deprivation
SNPs
renal cancer
bone health
bladder cancer
Precision Medicine Initiative
ED
genomics
OABurge incontinence
treatment decision-making
genotyping
quality of life
germline DNA
stages of prostate cancer
voiding dysfunction
treatment of fatigue in prostate cancer
minority health
pelvic pain
imaging
genitourinary dysfunction
resistance to cendroyen deprivation therapy
testicular cancer
urology nursing
frail elderly
metastatic prostate cancer
male health
spouses
prostate screening
geriatrics
active surveillance
plant-based diet
nocturia
castrate resistant prostate cancer
cancer related fatigue
lymph node excision
bone health in prostate cancer
new medications
biomarkers
genetic risk score
genetic testing
pharmaco economics
Identificationunj_ma19_03IssueMarch-April 2019VolumeVolume 39 Number 2
